English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Trovagene Inc.

Press release submission | Feb 14, 2019

TROVAGENE, INC.: Presents Update on Phase 2 Study of Onvansertib in Combination with Zytiga in Patients with mCRPC at ASCO-GU Conference

Jamie Barrand | Sep 23, 2015

Data looks favorable for Trovagene's HPV HR test

Trending

+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm

+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT

+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'

+ Regulatory
Patient Daily | May 12, 2025

Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily